A detailed history of Washington Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Washington Trust CO holds 4,465 shares of NVS stock, worth $516,198. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,465
Previous 4,455 0.22%
Holding current value
$516,198
Previous $430,000 10.47%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$92.57 - $107.37 $925 - $1,073
10 Added 0.22%
4,465 $475,000
Q2 2023

Jul 27, 2023

SELL
$92.52 - $104.91 $27,756 - $31,473
-300 Reduced 6.31%
4,455 $449,000
Q1 2023

May 10, 2023

BUY
$80.03 - $92.81 $356,213 - $413,097
4,451 Added 111275.0%
4,455 $409,000
Q1 2023

May 04, 2023

SELL
$80.03 - $92.81 $380,222 - $440,940
-4,751 Reduced 99.92%
4 $410,000
Q4 2022

Jul 27, 2023

BUY
$75.55 - $92.52 $22,665 - $27,756
300 Added 6.73%
4,755 $431,000
Q4 2022

Feb 08, 2023

BUY
$75.55 - $92.52 $113,325 - $138,780
1,500 Added 46.08%
4,755 $431,000
Q3 2022

Oct 14, 2022

BUY
$74.61 - $87.26 $37,305 - $43,630
500 Added 18.15%
3,255 $248,000
Q2 2022

Jul 25, 2022

SELL
$80.52 - $93.75 $6,361 - $7,406
-79 Reduced 2.79%
2,755 $233,000
Q1 2022

May 05, 2022

BUY
$80.11 - $90.62 $160 - $181
2 Added 0.07%
2,834 $249,000
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $159 - $176
2 Added 0.07%
2,832 $248,000
Q1 2021

Apr 28, 2021

SELL
$83.5 - $98.47 $13,944 - $16,444
-167 Reduced 5.57%
2,830 $242,000
Q4 2020

Feb 09, 2021

BUY
$78.07 - $94.43 $21,078 - $25,496
270 Added 9.9%
2,997 $283,000
Q3 2020

Nov 05, 2020

BUY
$82.14 - $91.0 $9,446 - $10,465
115 Added 4.4%
2,727 $237,000
Q2 2020

Aug 04, 2020

SELL
$80.93 - $91.1 $579,135 - $651,911
-7,156 Reduced 73.26%
2,612 $228,000
Q1 2020

May 07, 2020

BUY
$70.67 - $99.01 $690,304 - $967,129
9,768 New
9,768 $805,000
Q4 2019

Feb 12, 2020

SELL
$84.35 - $95.37 $533,598 - $603,310
-6,326 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$85.54 - $94.26 $157,906 - $174,003
-1,846 Reduced 22.59%
6,326 $553,000
Q2 2019

Aug 07, 2019

BUY
$75.4 - $92.8 $139,188 - $171,308
1,846 Added 29.18%
8,172 $747,000
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $109,590 - $125,348
-1,455 Reduced 18.7%
6,326 $518,000
Q4 2018

Feb 11, 2019

BUY
$73.66 - $82.02 $4,861 - $5,413
66 Added 0.86%
7,781 $668,000
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $3,347 - $3,871
50 Added 0.65%
7,715 $665,000
Q2 2018

Aug 10, 2018

BUY
$64.91 - $73.36 $497,535 - $562,304
7,665 New
7,665 $579,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.